Event Details

Phase 1: Where Science Becomes Medicine

Sunday, July 14, 2019 - Tuesday, July 16, 2019
Title
Phase 1: Where Science Becomes Medicine
Date / Time
Sunday, July 14, 2019 - Tuesday, July 16, 2019
Location
Hilton Deansgate, Manchester, United Kingdom

Notes

Poster presentations:

  • A Phase 1b Study of Oraxol in Combination with Ramucirumab in Patients with Gastric or Esophageal Cancers who failed previous chemotherapy
  • Oral paclitaxel for the treatment of metastatic breast cancer (MBC) patients
  • Phase 1 Trial Summary of Encequidar, a Novel P-glycoprotein (P-gp) Inhibitor to Enhance Oral Bioavailability of Chemotherapies
  • A pilot study of oral paclitaxel and encequidar in patients with cutaneous angiosarcomas (KX-ORAX-010)